LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy”

Photo by camstejim from unsplash

In our recently published study we found that at the onset of PML serum NfL were 10-fold higher than in the pre-PML condition and in natalizumab-treated or untreated MS patients.… Click to show full abstract

In our recently published study we found that at the onset of PML serum NfL were 10-fold higher than in the pre-PML condition and in natalizumab-treated or untreated MS patients. The findings by Loonstra et al., with four additional cases with an increase in serum NfL at PML onset, support our results and further explore the dynamics of these changes. In fact they showed that also in asymptomatic patients NfL were already increased, and that NfL levels mirror PML lesion volume. This suggests that NfL may represent an early and accessible marker of PML. This article is protected by copyright. All rights reserved.

Keywords: reply serum; biomarkers natalizumab; serum neurofilaments; candidate biomarkers; neurofilaments candidate; natalizumab progressive

Journal Title: Annals of Neurology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.